Anthem (NASDAQ:ANTX) Cut to Sell at Wall Street Zen

by · The Cerbat Gem

Wall Street Zen downgraded shares of Anthem (NASDAQ:ANTXFree Report) from a hold rating to a sell rating in a report published on Saturday morning.

Separately, Weiss Ratings assumed coverage on Anthem in a report on Tuesday, April 7th. They set a “sell (d-)” rating for the company. One investment analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $2.00.

View Our Latest Analysis on Anthem

Anthem Price Performance

Shares of NASDAQ:ANTX opened at $4.80 on Friday. Anthem has a 1-year low of $1.00 and a 1-year high of $6.91. The business has a fifty day moving average price of $3.17 and a 200-day moving average price of $1.86. The company has a market capitalization of $172.80 million, a PE ratio of -4.14 and a beta of -1.31.

Anthem (NASDAQ:ANTXGet Free Report) last issued its quarterly earnings results on Tuesday, March 17th. The company reported ($0.29) earnings per share for the quarter. On average, sell-side analysts anticipate that Anthem will post -0.91 earnings per share for the current fiscal year.

About Anthem

(Get Free Report)

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products.

Featured Stories